Aller au contenu

Rechercher dans la communauté

Affichage des résultats pour les étiquettes 'shot'.

  • Rechercher par étiquettes

    Saisir les étiquettes en les séparant par une virgule.
  • Rechercher par auteur

Type du contenu


Forums

  • Projets immobiliers
    • Propositions
    • En Construction
    • Complétés
    • Transports en commun
    • Infrastructures
    • Lieux de culture, sport et divertissement
  • Discussions générales
    • Urbanisme, architecture et technologies urbaines
    • Photographie urbaine
    • Discussions générales
    • Divertissement, Bouffe et Culture
    • L'actualité
    • Hors Sujet
  • Aviation MTLYUL
    • YUL Discussions générales
    • Spotting à YUL
  • Ici et ailleurs
    • Ville de Québec et le reste du Québec
    • Toronto et le reste du Canada
    • États-Unis d'Amérique
    • Projets ailleurs dans le monde.

Blogs

  • Blog MTLURB

Rechercher les résultats dans…

Rechercher les résultats qui…


Date de création

  • Début

    Fin


Dernière mise à jour

  • Début

    Fin


Filtrer par nombre de…

Inscription

  • Début

    Fin


Groupe


Location


Intérêts


Occupation


Type d’habitation

5 résultats trouvés

  1. Sorry for the late-night shot. But it looks like we're getting a full restoration of this nice old building. Before:
  2. Huge news! Days of Future Past that was shot here in 2013 grossed $745 million worldwide and cost over $200 million to shoot. The new film's budget could be $250 million + Starring Jennifer Lawrence, Hugh Jackman, Michael Fassbender, James McAvoy, Nicholas Hoult, Channing Tatum. Rumours of the original cast of Ian McKellen, Anna Paquin, Patrick Stewart, Halle Berry returning are also in the air. http://www.cjad.com/cjad-news/2014/09/04/x-men-returning-to-montreal
  3. Montréal 1957, Archives de la Ville de Montréal Francais: ( ) ( ) English: ( ) ( ) Where is the located (University at St-Antoine)? And when/why did the MGH stop flying the ?
  4. Consortium a welcome booster shot for pharmaceutical research PETER HADEKEL, The Gazette Published: 8 hours ago Up to $48 million over four years could be pumped into drug discovery in Quebec under an innovative new consortium that links governments, pharmaceutical companies and universities. The Quebec Consortium for Drug Discovery, announced last week by Economic Development Minster Raymond Bachand, could be a welcome shot in the arm for the pharmaceutical and biotech sectors in Montreal. The industry has a significant presence in Quebec, with 145 companies, nearly 21,000 jobs, and five centres for basic pharmaceutical research. About $550 million in new investments have been announced since 2006. But like the rest of the industry worldwide, the biopharmaceutical companies operating here have been struggling to find and develop the next generation of blockbuster drugs to treat more complex medical conditions. The easy discoveries have been made. For example, it's a lot easier to develop a product to lower blood pressure than one that enhances memory in an Alzheimer's patient. Meanwhile, regulatory requirements are rising amid public concern over drug safety and efficacy. And the cost and time it takes to develop a new drug and bring it to market continue to increase. Bachand hopes to create some new momentum and capitalize on the research strengths already here. The plan is to create a public-private partnership that will foster research at the pre-competitive stage. Private sector participants are AstraZeneca, Merck Frosst and Pfizer Canada, with each expected to kick in $5 million over five years. University players include McGill, the Université de Montréal, Université Laval and the Université de Sherbrooke. Government funding will come from Quebec's Ministry of Economic Development and its Fonds de la recherche en santé du Québec. The federal government has been asked to chip in through its Networks of Centres of Excellence program. Small biotech companies can also participate by applying for funding from the consortium for their own research projects. The initial amount of money may seem small, but the goal is to build new links between the players in Quebec, the consortium's director, Max Fehlmann, said in an interview. The emphasis will be on finding drug-discovery technologies that can benefit the entire industry rather than on finding new molecules per se, he said. The idea is to make that intellectual property available to other investors in the program, who would pay a licensing fee to the discoverer to access the findings. Quebec's program is modeled on similar ventures in Europe and the U.S. The difference, said Fehlmann, is those programs are government-run while this one will be steered by consortium members themselves. The drug venture is also inspired by a similar program in the province's aerospace sector. The Consortium for Research and Innovation in Aerospace in Quebec funds pre-competitive research and licenses the findings to its various industrial partners. Philippe Walker, vice-president of research at AstraZeneca Canada, says "the idea is to develop a kind of neutral, fertile ground where ideas could be exchanged." ne example, he says, could be to find new brain imaging techniques that would help to confirm a diagnosis of Alzheimer's disease and evaluate at an early stage whether new drugs are having an effect on the patient. "This could tap into the historical strengths of various groups in Montreal who have developed imaging technology. "There are a lot of good things happening in Quebec," Walker added. One reason AstraZeneca invested in its Montreal research facility was to be close to academic scientists working here in the pain research field. Collaboration is considered a key to creativity in drug science, because new discovery often comes at the intersection between two disciplines. "It's extremely difficult and complex to develop a new drug," Walker said. "The pharma industry in general, not only in Quebec, is suffering from a reduction in productivity if it's measured by the number of new (products) that are put on the market." On average, the drug industry spends between $800 million and $1.7 billion (over a 12-to-15 year period of research and development) to bring a new product to commercialization, U.S. data show. The Food and Drug Administration in the U.S. backed its collaboration initiative, known as Critical Path, in the hope that it would help to cut delays and costs. And backers of the venture in Quebec are betting it can lead to the same kinds of gains. phadekel@videotron.ca http://www.canada.com/montrealgazette/news/business/story.html?id=d2f98b6b-95bf-4681-9ac3-2de68e832fe2&p=1
  5. Just got my new camera, hope you like the pix! Some of these took a lot of work (crouching, sitting in weird positions, hardcore tripod action, dodging cars, people, dogs, etc... but it was fun) First photo taken with new camera, my cat trying to steal my food Let's go downtown... First night photo taken with new camera, testing out some things. This shot failed due to the cars stopped at the red light overloading the 15 second exposure. (I was anticipating the light to change but it didn't, boo.) Testing out the zoom on this baby! Now we're in business. University boul. Alright time for some HDR... First HDR with new camera! Buildings just before the mountain with lovely Canada/Quebec flags to piss off Habsfan/Malek/Yarabundi (Joke, j'vous aime!) Le 1000 la nuit Criss que j'adore ce gratte-ciel... I messed this one up, used incorrect settings, but here it is anyway. I also messed this one, but here it is anyway. The 1250 looks like a xmas tree! Le 400 en construction Le 400 en construction encore Les tours Lepine My favorite shot of the bunch : Tour de la Bourse.
×
×
  • Créer...